<div class="slide6-3">
	 <h1>ROCKET AF Studied Patients<br />Commonly Seen in Daily Practice</h1>
	 <p><em>In the landmark trial, Xarelto<sup>Â®</sup> was studied across a wide range of patients<sup>13</sup></em></p>
	 <div class="module clean">
		 <p>PATIENT DEMOGRAPHICS</p>
	 </div>

	 <table>
		<tr>
			 <td class="noborder"><br /></td>
			 <td class="xarelto noborder tableHead">Xarelto</td>
		 </tr>
		<tr>
			 <td>Age</td>
			 <td class="xarelto">73 years</td>
		 </tr>
		<tr>
			 <td>Hypertension</td>
			 <td class="xarelto">90%</td>
		 </tr>
		 <tr>
			 <td>Congestive heart failure</td>
			 <td class="xarelto">63%</td>
		 </tr>
		  <tr>
			 <td>Prior Stroke/TIA/Systemic embolism</td>
			 <td class="xarelto">55%</td>
		 </tr>
		<tr>
			 <td>Diabetes</td>
			 <td class="xarelto">40%</td>
		 </tr>
		<tr>
			 <td>Prior MI</td>
			 <td class="xarelto">17%</td>
		 </tr>
	 </table>
	 <div class="footnote">Patient demographics were well balanced between arms, with no statistical differences.</div>
</div>
